385 related articles for article (PubMed ID: 15577036)
1. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
Higuchi N; Maruyama H
Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
[TBL] [Abstract][Full Text] [Related]
2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
Kopeć J
Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
[TBL] [Abstract][Full Text] [Related]
4. Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.
Gejyo F; Kawaguchi Y; Hara S; Nakazawa R; Azuma N; Ogawa H; Koda Y; Suzuki M; Kaneda H; Kishimoto H; Oda M; Ei K; Miyazaki R; Maruyama H; Arakawa M; Hara M
Artif Organs; 2004 Apr; 28(4):371-80. PubMed ID: 15084199
[TBL] [Abstract][Full Text] [Related]
5. Survey of the effects of a column for adsorption of β2-microglobulin in patients with dialysis-related amyloidosis in Japan.
Gejyo F; Amano I; Ando T; Ishida M; Obayashi S; Ogawa H; Ono T; Kanno Y; Kitaoka T; Kukita K; Kurihara S; Sato M; Shin J; Suzuki M; Takahashi S; Taguma Y; Takemoto Y; Nakazawa R; Nakanishi T; Nakamura H; Hara S; Hiramatsu M; Furuya R; Masakane I; Tsuchida K; Motomiya Y; Morita H; Yamagata K; Yoshiya K; Yamakawa T;
Ther Apher Dial; 2013 Feb; 17(1):40-7. PubMed ID: 23379492
[TBL] [Abstract][Full Text] [Related]
6. Beta2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis.
Suzuki K; Shimazaki M; Kutsuki H
Ther Apher Dial; 2003 Feb; 7(1):104-7. PubMed ID: 12921124
[TBL] [Abstract][Full Text] [Related]
7. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
Floege J; Koch KM
Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
[No Abstract] [Full Text] [Related]
8. Amyloidosis and its impact on patients with ESRD.
Copeland SD
Nephrol Nurs J; 2006; 33(1):31-3; quiz 34-5. PubMed ID: 16538926
[TBL] [Abstract][Full Text] [Related]
9. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration.
Fry AC; Singh DK; Chandna SM; Farrington K
Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712
[TBL] [Abstract][Full Text] [Related]
10. Dialysis-related amyloidosis: late finding or hidden epidemic?
Dember LM; Jaber BL
Semin Dial; 2006; 19(2):105-9. PubMed ID: 16551286
[TBL] [Abstract][Full Text] [Related]
11. Beta2-microglobulin.
Drüeke TB; Massy ZA
Semin Dial; 2009; 22(4):378-80. PubMed ID: 19708985
[TBL] [Abstract][Full Text] [Related]
12. beta2-microglobulin-derived amyloidosis: an update.
Floege J; Ketteler M
Kidney Int Suppl; 2001 Feb; 78():S164-71. PubMed ID: 11169004
[TBL] [Abstract][Full Text] [Related]
13. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
Gejyo F; Homma N; Arakawa M
Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the role of flux in beta2-microglobulin removal.
Hoenich NA
Blood Purif; 2007; 25(5-6):430-1. PubMed ID: 17957096
[No Abstract] [Full Text] [Related]
15. Long-term efficacy and safety of the small-sized β2-microglobulin adsorption column for dialysis-related amyloidosis.
Yamamoto Y; Hirawa N; Yamaguchi S; Ogawa N; Takeda H; Shibuya K; Kawahara K; Kojima H; Dobashi Y; Fujita M; Azusima K; Miyazaki N; Kobayashi M; Kobayashi C; Fujiwara A; Yuto J; Saka S; Yatsu K; Toya Y; Yasuda G; Ohnishi T; Umemura S
Ther Apher Dial; 2011 Oct; 15(5):466-74. PubMed ID: 21974700
[TBL] [Abstract][Full Text] [Related]
16. Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis.
Hiyama E; Hyodo T; Kondo M; Otsuka K; Honma T; Taira T; Yoshida K; Uchida T; Endo T; Sakai T; Baba S; Hidai H
Nephron; 2002 Oct; 92(2):501-2. PubMed ID: 12218344
[No Abstract] [Full Text] [Related]
17. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility study on cuprophane and polysulphone dialysers.
Taraba I; Polner K; Makó J
Nephrol Dial Transplant; 1991; 6 Suppl 3():22-5. PubMed ID: 1775261
[No Abstract] [Full Text] [Related]
19. Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis.
Abe T; Uchita K; Orita H; Kamimura M; Oda M; Hasegawa H; Kobata H; Fukunishi M; Shimazaki M; Abe T; Akizawa T; Ahmad S
Kidney Int; 2003 Oct; 64(4):1522-8. PubMed ID: 12969174
[TBL] [Abstract][Full Text] [Related]
20. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
Saito A; Gejyo F
Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
